METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.

Mol Cancer · 2019 · PMC6588935 · PMID 31228940

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, at the level of its mRNA, the prognostic analysis of METTL3 from tumor samples with detailed clinical information which were downloaded from TCGA database showed a trend of adverse prognosis in both METTL3 and bladder cancer, but it had no statistical significance (Additional file 3 : Figure S1b).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.